Pyxis Oncology

(NASDAQ) PYXS

Current Price$1.80

Market Cap$112.77M

Since IPO (2021)-87%

5 YearN/A

1 Year+44%

1 Month+8%

Pyxis Oncology Financials at a Glance

Market Cap

$112.77M

Revenue (TTM)

$13.86M

Net Income (TTM)

-$81.74M

EPS (TTM)

-$1.30

P/E Ratio

-1.37

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.80

Volume

17,904

Open

$1.75

Price

$1.80

Volume

17,904

Open

$1.75

Previous Close

$1.80

Daily Range

$1.75 - $1.87

52-Week Range

$0.97 - $5.55

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.80

Volume

17,904

Open

$1.75

Previous Close

$1.80

Daily Range

$1.75 - $1.87

52-Week Range

$0.97 - $5.55

PYXS News

No articles available.

PYXS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pyxis Oncology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Thomas Civik, MBA

Website

www.pyxisoncology.com

Headquarters

Boston, MA 02140, US

PYXS Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-6%

Net Income Margin

-6%

Return on Equity

-122%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-72.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$112.77M

Shares Outstanding

63.36M

Volume

17.90K

Avg. Volume

490.25K

Financials (TTM)

Gross Profit

$11.47M

Operating Income

-$84.42M

EBITDA

-$79.91M

Operating Cash Flow

-$63.50M

Capital Expenditure

-$9.00K

Free Cash Flow

-$63.51M

Cash & ST Invst.

$66.86M

Total Debt

$18.67M

Pyxis Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$459.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$112.77M

N/A

Market Cap/Employee

$2.56M

N/A

Employees

N/A

Net Income

-$23.27M

-10.0%

EBITDA

-$23.90M

-6.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$24.23M

-71.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$16.50M

-10.0%

Short Term Debt

$1.76M

+16.5%

Return on Assets

-1.27%

N/A

Return on Invested Capital

-1.80%

N/A

Free Cash Flow

-$26.00M

-15.4%

Operating Cash Flow

-$26.00M

-15.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TNYATenaya Therapeutics, Inc.

TNYATenaya Therapeutics, Inc.$0.87+8.77%

IMRXImmuneering Corporation

IMRXImmuneering Corporation$5.77+14.03%

HUMAHumacyte, Inc.

HUMAHumacyte, Inc.$1.30+1.56%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.87-0.77%

CRBUCaribou Biosciences, Inc.

CRBUCaribou Biosciences, Inc.$2.36+2.16%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.28+0.23%

ZURAZura Bio Limited

ZURAZura Bio Limited$4.30+2.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

TAT&T

TAT&T$24.80-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.92-0.03%

Questions About PYXS

What is the current price of Pyxis Oncology?

Pyxis Oncology is trading at $1.80 per share.

What is the 52-week range for Pyxis Oncology?

Over the past 52 weeks, Pyxis Oncology has traded between $0.97 and $5.55.

How much debt does Pyxis Oncology have?

As of the most recent reporting period, Pyxis Oncology reported total debt of $18.26M.

How much cash does Pyxis Oncology have on hand?

Pyxis Oncology reported $7.24M in cash and cash equivalents in its most recent financial results.

What is Pyxis Oncology’s dividend yield?

Pyxis Oncology does not currently have a dividend yield.

Pyxis Oncology

Pyxis Oncology Financials at a Glance

PYXS News

PYXS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pyxis Oncology

PYXS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pyxis Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PYXS

What is the current price of Pyxis Oncology?

What is the 52-week range for Pyxis Oncology?

How much debt does Pyxis Oncology have?

How much cash does Pyxis Oncology have on hand?

What is Pyxis Oncology’s dividend yield?

Premium Investing Services